{"id": "article-22494_0", "title": "Hallervorden-Spatz Disease -- Continuing Education Activity", "content": "Hallervorden-Spatz disease, now known as pantothenate kinase-associated neurodegeneration (PKAN), is a rare autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain nuclei and characterized by progressive extrapyramidal dysfunction and dementia. Classically, the disease presents between ages 7 and 15 years. However, the disease onset has been reported in all age groups, including infancy and adulthood. As PKAN has an autosomal mode of inheritance, each sibling of an individual has a 25% chance of being affected and a 50% chance of being an asymptomatic carrier. This activity reviews the evaluation and management of pantothenate kinase-associated neurodegeneration and highlights the role of the interprofessional team in the care of affected patients and their families.", "contents": "Hallervorden-Spatz Disease -- Continuing Education Activity. Hallervorden-Spatz disease, now known as pantothenate kinase-associated neurodegeneration (PKAN), is a rare autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain nuclei and characterized by progressive extrapyramidal dysfunction and dementia. Classically, the disease presents between ages 7 and 15 years. However, the disease onset has been reported in all age groups, including infancy and adulthood. As PKAN has an autosomal mode of inheritance, each sibling of an individual has a 25% chance of being affected and a 50% chance of being an asymptomatic carrier. This activity reviews the evaluation and management of pantothenate kinase-associated neurodegeneration and highlights the role of the interprofessional team in the care of affected patients and their families."}
{"id": "article-22494_1", "title": "Hallervorden-Spatz Disease -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of pantothenate kinase-associated neurodegeneration. Describe the typical presentation of a patient with pantothenate kinase-associated neurodegeneration. Describe the risk of the affected child's mother having another child with pantothenate kinase-associated neurodegeneration. Describe the importance of improving care coordination amongst interprofessional team members to improve care for patients affected by pantothenate kinase-associated neurodegeneration and to provide appropriate counsel to their families. Access free multiple choice questions on this topic.", "contents": "Hallervorden-Spatz Disease -- Continuing Education Activity. Objectives: Describe the pathophysiology of pantothenate kinase-associated neurodegeneration. Describe the typical presentation of a patient with pantothenate kinase-associated neurodegeneration. Describe the risk of the affected child's mother having another child with pantothenate kinase-associated neurodegeneration. Describe the importance of improving care coordination amongst interprofessional team members to improve care for patients affected by pantothenate kinase-associated neurodegeneration and to provide appropriate counsel to their families. Access free multiple choice questions on this topic."}
{"id": "article-22494_2", "title": "Hallervorden-Spatz Disease -- Introduction", "content": "Hallervorden-Spatz disease, now more commonly known as pantothenate kinase-associated neurodegeneration (PKAN), is a rare autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain nuclei and characterized by progressive extrapyramidal dysfunction and dementia. [1] [2] [3]", "contents": "Hallervorden-Spatz Disease -- Introduction. Hallervorden-Spatz disease, now more commonly known as pantothenate kinase-associated neurodegeneration (PKAN), is a rare autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain nuclei and characterized by progressive extrapyramidal dysfunction and dementia. [1] [2] [3]"}
{"id": "article-22494_3", "title": "Hallervorden-Spatz Disease -- Etiology", "content": "Hallervorden Spatz disease was first described in 1922 by two German physicians, Hallervorden and Spatz, as a form of familial brain degeneration characterized by cerebral iron deposition and hence the name so.\u00a0It is a subset of\u00a0Neurodegeneration with brain iron accumulation (NBIA), in the basal ganglia, with subsequent variable neurological dysfunction.\u00a0Numerous genes (at least 10)\u00a0have been identified, resulting in a variety of specific diseases.", "contents": "Hallervorden-Spatz Disease -- Etiology. Hallervorden Spatz disease was first described in 1922 by two German physicians, Hallervorden and Spatz, as a form of familial brain degeneration characterized by cerebral iron deposition and hence the name so.\u00a0It is a subset of\u00a0Neurodegeneration with brain iron accumulation (NBIA), in the basal ganglia, with subsequent variable neurological dysfunction.\u00a0Numerous genes (at least 10)\u00a0have been identified, resulting in a variety of specific diseases."}
{"id": "article-22494_4", "title": "Hallervorden-Spatz Disease -- Etiology", "content": "The exact etiology of\u00a0PKAN is not well understood. One of the proposed hypotheses is that aberrant oxidation of lipofuscin to neuromelanin and insufficient cysteine dioxygenase lead to abnormal iron accumulation in the brain. While portions of the globus pallidus and pars reticularis of substantia nigra have relatively higher\u00a0iron content in healthy individuals, individuals with\u00a0PKAN have excessive amounts of iron accumulated in these nuclei.", "contents": "Hallervorden-Spatz Disease -- Etiology. The exact etiology of\u00a0PKAN is not well understood. One of the proposed hypotheses is that aberrant oxidation of lipofuscin to neuromelanin and insufficient cysteine dioxygenase lead to abnormal iron accumulation in the brain. While portions of the globus pallidus and pars reticularis of substantia nigra have relatively higher\u00a0iron content in healthy individuals, individuals with\u00a0PKAN have excessive amounts of iron accumulated in these nuclei."}
{"id": "article-22494_5", "title": "Hallervorden-Spatz Disease -- Etiology", "content": "A role for mutation in the PANK2 gene (band 20p13) accounts for most inherited\u00a0PKAN cases as the etiology of\u00a0PKAN\u00a0in various studies. \u00a0Mutations result in an autosomal recessive inborn error of coenzyme A metabolism with a resultant deficiency of pantothenate kinase enzyme, which may lead to the accumulation of cysteine and cysteine-containing compounds in the basal ganglia. This causes chelation of iron in the globus pallidus and other basal ganglia and rapid auto-oxidation of cysteine in the presence of iron with subsequent free radical production. Pathologic examination reveals characteristic rust-brown discoloration of the globus pallidus and substantia nigra pars reticularis due to underlying iron deposition and a reduction in the size of these nuclei. Generalized atrophy of the brain parenchyma may be seen in severely advanced cases. [4] [5]", "contents": "Hallervorden-Spatz Disease -- Etiology. A role for mutation in the PANK2 gene (band 20p13) accounts for most inherited\u00a0PKAN cases as the etiology of\u00a0PKAN\u00a0in various studies. \u00a0Mutations result in an autosomal recessive inborn error of coenzyme A metabolism with a resultant deficiency of pantothenate kinase enzyme, which may lead to the accumulation of cysteine and cysteine-containing compounds in the basal ganglia. This causes chelation of iron in the globus pallidus and other basal ganglia and rapid auto-oxidation of cysteine in the presence of iron with subsequent free radical production. Pathologic examination reveals characteristic rust-brown discoloration of the globus pallidus and substantia nigra pars reticularis due to underlying iron deposition and a reduction in the size of these nuclei. Generalized atrophy of the brain parenchyma may be seen in severely advanced cases. [4] [5]"}
{"id": "article-22494_6", "title": "Hallervorden-Spatz Disease -- Epidemiology", "content": "According to some studies prevalence of PKAN is 1-9/1000000. The classic presentation is in the late part of the first decade or the early part of the second decade, between ages 7 and 15 years. However, the disease onset has been reported in all age groups, including infancy and adulthood.", "contents": "Hallervorden-Spatz Disease -- Epidemiology. According to some studies prevalence of PKAN is 1-9/1000000. The classic presentation is in the late part of the first decade or the early part of the second decade, between ages 7 and 15 years. However, the disease onset has been reported in all age groups, including infancy and adulthood."}
{"id": "article-22494_7", "title": "Hallervorden-Spatz Disease -- Pathophysiology", "content": "The mechanism by which basal ganglia iron uptake is increased in PKAN\u00a0is unknown since systemic and cerebrospinal fluid iron levels, as well as plasma ferritin, transferrin, and ceruloplasmin, all are normal. One of the proposed mechanisms is that aberrant oxidation of lipofuscin to neuromelanin and insufficient cysteine dioxygenase leads to abnormal iron in the brain. While portions of the globus pallidus and pars reticularis of substantia nigra have high iron content in healthy individuals, individuals with\u00a0PKAN have excess amounts of iron deposited in these nuclei. A role for mutation in the PANK2 gene (band 20p13) accounts for most inherited\u00a0PKAN cases in the etiology of\u00a0PKAN\u00a0in various studies. Mutations result in an autosomal recessive inborn error of coenzyme A metabolism with a resultant deficiency of pantothenate kinase may lead to the accretion of cysteine and cysteine-containing compounds in the basal ganglia. This causes chelation of iron in the globus pallidus and rapid auto-oxidation of cysteine in the presence of iron with subsequent free radical generation.", "contents": "Hallervorden-Spatz Disease -- Pathophysiology. The mechanism by which basal ganglia iron uptake is increased in PKAN\u00a0is unknown since systemic and cerebrospinal fluid iron levels, as well as plasma ferritin, transferrin, and ceruloplasmin, all are normal. One of the proposed mechanisms is that aberrant oxidation of lipofuscin to neuromelanin and insufficient cysteine dioxygenase leads to abnormal iron in the brain. While portions of the globus pallidus and pars reticularis of substantia nigra have high iron content in healthy individuals, individuals with\u00a0PKAN have excess amounts of iron deposited in these nuclei. A role for mutation in the PANK2 gene (band 20p13) accounts for most inherited\u00a0PKAN cases in the etiology of\u00a0PKAN\u00a0in various studies. Mutations result in an autosomal recessive inborn error of coenzyme A metabolism with a resultant deficiency of pantothenate kinase may lead to the accretion of cysteine and cysteine-containing compounds in the basal ganglia. This causes chelation of iron in the globus pallidus and rapid auto-oxidation of cysteine in the presence of iron with subsequent free radical generation."}
{"id": "article-22494_8", "title": "Hallervorden-Spatz Disease -- Pathophysiology", "content": "Pathologic examination reveals characteristic rust-brown discoloration of the globus pallidus and substantia nigra pars reticularis due to iron deposition and a reduction in the size of the caudate nuclei, substantia nigra, and tegmentum, as well as generalized atrophy of the brain. Microscopically marked neuroaxonal and myelin degeneration is a distinctive pathologic feature of PKAN. Ubiquitinated spheroids, which represent swollen axons with vacuolated cytoplasm\u00a0inactivated by attachment of ubiquitin, are\u00a0found most abundantly in the pallidonigral system\u00a0and in the cerebral cortex. Accumulation of \u00a0iron-containing pigment, mostly neuromelanin, and ceroid lipofuscin, in the palladonigral system", "contents": "Hallervorden-Spatz Disease -- Pathophysiology. Pathologic examination reveals characteristic rust-brown discoloration of the globus pallidus and substantia nigra pars reticularis due to iron deposition and a reduction in the size of the caudate nuclei, substantia nigra, and tegmentum, as well as generalized atrophy of the brain. Microscopically marked neuroaxonal and myelin degeneration is a distinctive pathologic feature of PKAN. Ubiquitinated spheroids, which represent swollen axons with vacuolated cytoplasm\u00a0inactivated by attachment of ubiquitin, are\u00a0found most abundantly in the pallidonigral system\u00a0and in the cerebral cortex. Accumulation of \u00a0iron-containing pigment, mostly neuromelanin, and ceroid lipofuscin, in the palladonigral system"}
{"id": "article-22494_9", "title": "Hallervorden-Spatz Disease -- History and Physical", "content": "Hellervorden Spatz Disease or PKAN is characterized by progressive dystonia, a motor disorder of extrapyramidal type with gait difficulty. In classic form, usually, onset\u00a0occurs\u00a0in the first decade. Clinical manifestations of Hellervorden Spatz disease or PKAN vary from patient to patient. Patients with this disease suffer from a variety of other neurological symptoms and signs, including:", "contents": "Hallervorden-Spatz Disease -- History and Physical. Hellervorden Spatz Disease or PKAN is characterized by progressive dystonia, a motor disorder of extrapyramidal type with gait difficulty. In classic form, usually, onset\u00a0occurs\u00a0in the first decade. Clinical manifestations of Hellervorden Spatz disease or PKAN vary from patient to patient. Patients with this disease suffer from a variety of other neurological symptoms and signs, including:"}
{"id": "article-22494_10", "title": "Hallervorden-Spatz Disease -- History and Physical", "content": "Extrapyramidal symptoms Dystonia, dysarthria, muscular rigidity, spasms, Parkinson-like symptoms. Dystonia \u00a0(continuous spasms and muscle contractions)- A prominent and early feature Tremors, rarely bradykinesia (slowness of movement) and Choreoathetosis(involuntary movements in\u00a0along\u00a0with chorea(irregular migrating contractions) and athetosis (twisting and writhing) Significant speech disturbances - Can occur early Dysphagia - A common symptom; caused by rigidity of muscles and \u00a0associated corticobulbar abnormality Dementia - Present in most patients\u00a0with PKAN Visual impairment - Consequence of optic atrophy or retinal degeneration; can be the presenting symptom of the disease, although this is rare Seizures - Have been reported frequently Akathesis- (feeling of internal motor restlessness that can present as tension, nervousness, or anxiety) Neuropsychiatric dysfunction Optic atrophy Retinal degeneration", "contents": "Hallervorden-Spatz Disease -- History and Physical. Extrapyramidal symptoms Dystonia, dysarthria, muscular rigidity, spasms, Parkinson-like symptoms. Dystonia \u00a0(continuous spasms and muscle contractions)- A prominent and early feature Tremors, rarely bradykinesia (slowness of movement) and Choreoathetosis(involuntary movements in\u00a0along\u00a0with chorea(irregular migrating contractions) and athetosis (twisting and writhing) Significant speech disturbances - Can occur early Dysphagia - A common symptom; caused by rigidity of muscles and \u00a0associated corticobulbar abnormality Dementia - Present in most patients\u00a0with PKAN Visual impairment - Consequence of optic atrophy or retinal degeneration; can be the presenting symptom of the disease, although this is rare Seizures - Have been reported frequently Akathesis- (feeling of internal motor restlessness that can present as tension, nervousness, or anxiety) Neuropsychiatric dysfunction Optic atrophy Retinal degeneration"}
{"id": "article-22494_11", "title": "Hallervorden-Spatz Disease -- History and Physical", "content": "Approximately 25% of individuals have an 'atypical' presentation with onset later in life (onset mostly in a second and third decade), delay of extrapyramidal dysfunction for several years, and more gradual progression of the disease process. Prominent speech defects, spasticity, and psychiatric disturbances also dominate in the atypical form.", "contents": "Hallervorden-Spatz Disease -- History and Physical. Approximately 25% of individuals have an 'atypical' presentation with onset later in life (onset mostly in a second and third decade), delay of extrapyramidal dysfunction for several years, and more gradual progression of the disease process. Prominent speech defects, spasticity, and psychiatric disturbances also dominate in the atypical form."}
{"id": "article-22494_12", "title": "Hallervorden-Spatz Disease -- History and Physical", "content": "Based on the common clinical features, the following diagnostic criteria have been proposed. For a definitive diagnosis, all of the obligate findings and, at minimum, two\u00a0of the corroborative findings should be present. Obligate features of\u00a0PKAN \u00a0are the following: Onset in the first two decades of life Progression of signs and symptoms; classic form: loss of ambulation occurring within 10-15 years of onset; atypical form: ambulatory loss occurs within 15-40 years of disease onset. Evidence of extrapyramidal dysfunction, including one or more of these neurological impairments: dystonia, rigidity, and choreoathetosis. Corroborative features are listed as follows:", "contents": "Hallervorden-Spatz Disease -- History and Physical. Based on the common clinical features, the following diagnostic criteria have been proposed. For a definitive diagnosis, all of the obligate findings and, at minimum, two\u00a0of the corroborative findings should be present. Obligate features of\u00a0PKAN \u00a0are the following: Onset in the first two decades of life Progression of signs and symptoms; classic form: loss of ambulation occurring within 10-15 years of onset; atypical form: ambulatory loss occurs within 15-40 years of disease onset. Evidence of extrapyramidal dysfunction, including one or more of these neurological impairments: dystonia, rigidity, and choreoathetosis. Corroborative features are listed as follows:"}
{"id": "article-22494_13", "title": "Hallervorden-Spatz Disease -- History and Physical", "content": "Corticospinal tract involvement: spasticity, hyperreflexia, and extensor toe signs Progressive intellectual deterioration Retinitis pigmentosa and/or optic atrophy( seen with electroretinogram or visual field testing) Seizures Family history consistent with autosomal recessive inheritance( may include consanguinity) Hypointense areas on magnetic resonance imaging (MRI) in \u00a0the involved \u00a0basal ganglia Abnormal cytosomes in circulating lymphocytes Red blood cell acanthocytosis", "contents": "Hallervorden-Spatz Disease -- History and Physical. Corticospinal tract involvement: spasticity, hyperreflexia, and extensor toe signs Progressive intellectual deterioration Retinitis pigmentosa and/or optic atrophy( seen with electroretinogram or visual field testing) Seizures Family history consistent with autosomal recessive inheritance( may include consanguinity) Hypointense areas on magnetic resonance imaging (MRI) in \u00a0the involved \u00a0basal ganglia Abnormal cytosomes in circulating lymphocytes Red blood cell acanthocytosis"}
{"id": "article-22494_14", "title": "Hallervorden-Spatz Disease -- Evaluation -- CT Imaging", "content": "CT is\u00a0not very helpful in the diagnosis of\u00a0PKAN, but rarely hypodensity in the basal ganglia, and some atrophy of the brain has been reported. Calcification in the basal ganglia in the absence of any atrophy has also been described.", "contents": "Hallervorden-Spatz Disease -- Evaluation -- CT Imaging. CT is\u00a0not very helpful in the diagnosis of\u00a0PKAN, but rarely hypodensity in the basal ganglia, and some atrophy of the brain has been reported. Calcification in the basal ganglia in the absence of any atrophy has also been described."}
{"id": "article-22494_15", "title": "Hallervorden-Spatz Disease -- Evaluation -- Brain MRI", "content": "Is the standard in the diagnostic evaluation of all forms of Neurodegeneration with brain iron accumulation (NBIA) . It  has significantly increased the likelihood of a diagnosis of PKAN. Imaging findings are most conspicuous on T2W \u00a0sequences which demonstrate hypointensity reflecting areas of iron deposition, mainly in globi pallidi, \u00a0pars reticulata of the substantia nigra, and red nuclei. \u00a0Studies report that all patients with PANK2 mutations, whether classic or atypical, have\u00a0the characteristic radiologic sign known as the \"eye of the tiger\" on brain MRI, which is evident as bilateral symmetrical, central foci of hyperintense signals in the anteromedial globus pallidus, with a surrounding zone of hypointensity in the globus pallidus on T2W MR scanning. The central T2 relatively hyperintense spot or line within the globi pallidi is due to gliosis and vacuolization. This sign was not reported in patients without PANK2 mutations.\u00a0 The cortex is usually spared, but\u00a0atrophy can be seen in advanced cases.", "contents": "Hallervorden-Spatz Disease -- Evaluation -- Brain MRI. Is the standard in the diagnostic evaluation of all forms of Neurodegeneration with brain iron accumulation (NBIA) . It  has significantly increased the likelihood of a diagnosis of PKAN. Imaging findings are most conspicuous on T2W \u00a0sequences which demonstrate hypointensity reflecting areas of iron deposition, mainly in globi pallidi, \u00a0pars reticulata of the substantia nigra, and red nuclei. \u00a0Studies report that all patients with PANK2 mutations, whether classic or atypical, have\u00a0the characteristic radiologic sign known as the \"eye of the tiger\" on brain MRI, which is evident as bilateral symmetrical, central foci of hyperintense signals in the anteromedial globus pallidus, with a surrounding zone of hypointensity in the globus pallidus on T2W MR scanning. The central T2 relatively hyperintense spot or line within the globi pallidi is due to gliosis and vacuolization. This sign was not reported in patients without PANK2 mutations.\u00a0 The cortex is usually spared, but\u00a0atrophy can be seen in advanced cases."}
{"id": "article-22494_16", "title": "Hallervorden-Spatz Disease -- Evaluation -- SWI/T2*", "content": "Show susceptibility artifact (blooming low signal) in corresponding areas due to iron accretion. MR spectroscopy shows decreased NAA peak due to neuronal loss and may depict increased myoinositol.", "contents": "Hallervorden-Spatz Disease -- Evaluation -- SWI/T2*. Show susceptibility artifact (blooming low signal) in corresponding areas due to iron accretion. MR spectroscopy shows decreased NAA peak due to neuronal loss and may depict increased myoinositol."}
{"id": "article-22494_17", "title": "Hallervorden-Spatz Disease -- Evaluation -- SPECT Scanning", "content": "Iodine-123 (\u00a0I)-beta-carbomethoxy-3beta-(4-fluorophenyl) tropane \u00a0SPECT scanning and (\u00a0I)-iodobenzamide (IBZM)-SPECT scanning have been used in making the diagnosis of Hellervorden Spatz disease but are not commonly used in the clinical setup.", "contents": "Hallervorden-Spatz Disease -- Evaluation -- SPECT Scanning. Iodine-123 (\u00a0I)-beta-carbomethoxy-3beta-(4-fluorophenyl) tropane \u00a0SPECT scanning and (\u00a0I)-iodobenzamide (IBZM)-SPECT scanning have been used in making the diagnosis of Hellervorden Spatz disease but are not commonly used in the clinical setup."}
{"id": "article-22494_18", "title": "Hallervorden-Spatz Disease -- Evaluation -- Antenatal Diagnosis", "content": "Prenatal testing for pregnancies at risk is through\u00a0DNA testing. Cells are usually obtained by amniocentesis at 15 to 20 weeks of gestation or by chorionic villus sampling at 10 to 13 weeks. At least one mutation in the proband of extracted DNA should be present for a prenatal diagnosis of NBIA. If both pathogenic variants have been found in an affected family member, carrier testing for at-risk relatives is possible by the same technique.", "contents": "Hallervorden-Spatz Disease -- Evaluation -- Antenatal Diagnosis. Prenatal testing for pregnancies at risk is through\u00a0DNA testing. Cells are usually obtained by amniocentesis at 15 to 20 weeks of gestation or by chorionic villus sampling at 10 to 13 weeks. At least one mutation in the proband of extracted DNA should be present for a prenatal diagnosis of NBIA. If both pathogenic variants have been found in an affected family member, carrier testing for at-risk relatives is possible by the same technique."}
{"id": "article-22494_19", "title": "Hallervorden-Spatz Disease -- Treatment / Management", "content": "The treatment of patients with Hellervorden Spatz disease or PKAN\u00a0is mostly symptomatic. The tremors best respond to dopaminergic agents. \u00a0For rigidity and spasticity, dopamine agonists and anticholinergic agents alone or in combination may be used. \u00a0Intrathecal or oral Baclofen in moderate doses relieves stiffness and spasms and can reduce dystonia. \u00a0Intramuscular botulinum toxin has also been used for the alleviation of hypertonicity. \u00a0Benzodiazepines have been used for choreoathetotic movements.\u00a0Medications such as methscopolamine bromide can be attempted for excessive drooling. Dysarthria could respond to medications employed for rigidity and spasticity. A multidisciplinary team approach, including physical and speech therapy, swallowing evaluation, dietary assessment, gastrostomy tube feeding, and computer-assisted devices, may be used in advanced cases to\u00a0improve functional and communication skills. [6] [7] [8]", "contents": "Hallervorden-Spatz Disease -- Treatment / Management. The treatment of patients with Hellervorden Spatz disease or PKAN\u00a0is mostly symptomatic. The tremors best respond to dopaminergic agents. \u00a0For rigidity and spasticity, dopamine agonists and anticholinergic agents alone or in combination may be used. \u00a0Intrathecal or oral Baclofen in moderate doses relieves stiffness and spasms and can reduce dystonia. \u00a0Intramuscular botulinum toxin has also been used for the alleviation of hypertonicity. \u00a0Benzodiazepines have been used for choreoathetotic movements.\u00a0Medications such as methscopolamine bromide can be attempted for excessive drooling. Dysarthria could respond to medications employed for rigidity and spasticity. A multidisciplinary team approach, including physical and speech therapy, swallowing evaluation, dietary assessment, gastrostomy tube feeding, and computer-assisted devices, may be used in advanced cases to\u00a0improve functional and communication skills. [6] [7] [8]"}
{"id": "article-22494_20", "title": "Hallervorden-Spatz Disease -- Treatment / Management", "content": "Dementia is gradual\u00a0and progressive and usually does not\u00a0respond to treatments.\u00a0 Affected individuals with recurrent tongue biting due to severe Oro buccolingual dystonia, bite blocks, and\u00a0full-mouth dental extraction may be the only effective measure. \u00a0The use of systemic chelating agents, such as desferrioxamine, has been attempted to remove excess iron from the brain, but it didn't prove beneficial.\u00a0Research and trials for the administration of coenzyme A and high dosage of pantothenate are still in progress. However, no conclusive data are available.", "contents": "Hallervorden-Spatz Disease -- Treatment / Management. Dementia is gradual\u00a0and progressive and usually does not\u00a0respond to treatments.\u00a0 Affected individuals with recurrent tongue biting due to severe Oro buccolingual dystonia, bite blocks, and\u00a0full-mouth dental extraction may be the only effective measure. \u00a0The use of systemic chelating agents, such as desferrioxamine, has been attempted to remove excess iron from the brain, but it didn't prove beneficial.\u00a0Research and trials for the administration of coenzyme A and high dosage of pantothenate are still in progress. However, no conclusive data are available."}
{"id": "article-22494_21", "title": "Hallervorden-Spatz Disease -- Differential Diagnosis", "content": "GM gangliosidoses Huntington disease Juvenile neuronal ceroid lipofuscinosis Machado-Joseph disease Neuroacanthocytosis Neuronal ceroid lipofuscinosis Wilson disease", "contents": "Hallervorden-Spatz Disease -- Differential Diagnosis. GM gangliosidoses Huntington disease Juvenile neuronal ceroid lipofuscinosis Machado-Joseph disease Neuroacanthocytosis Neuronal ceroid lipofuscinosis Wilson disease"}
{"id": "article-22494_22", "title": "Hallervorden-Spatz Disease -- Pearls and Other Issues", "content": "As\u00a0PKAN has an autosomal mode of inheritance, each sibling of an individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being asymptomatic and not a carrier.", "contents": "Hallervorden-Spatz Disease -- Pearls and Other Issues. As\u00a0PKAN has an autosomal mode of inheritance, each sibling of an individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being asymptomatic and not a carrier."}
{"id": "article-22494_23", "title": "Hallervorden-Spatz Disease -- Enhancing Healthcare Team Outcomes", "content": "PKAN is best managed by an interprofessional team that includes nurses, geneticists, and counselors. The disorder has no cure and is progressive. Genetic testing should be offered to the parents, and counseling provided. The prognosis for most patients is very poor.", "contents": "Hallervorden-Spatz Disease -- Enhancing Healthcare Team Outcomes. PKAN is best managed by an interprofessional team that includes nurses, geneticists, and counselors. The disorder has no cure and is progressive. Genetic testing should be offered to the parents, and counseling provided. The prognosis for most patients is very poor."}
{"id": "article-22494_24", "title": "Hallervorden-Spatz Disease -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Hallervorden-Spatz Disease -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}